The purpose of this study was to examine whether facial flushing after drinking influences the relationship between alcohol consumption and prostatic hyperplasia among Korean men. Methods: The subjects were 957 Korean men (180 non-drinkers, 389 with drinking-related facial flushing, 388 without facial flushing) in the 40-69 age group, who underwent prostate ultrasound at the health promotion center of Chungnam National University Hospital between 2008 and 2014. Alcohol consumption and alcohol-related facial flushing were assessed through a questionnaire. In terms of the amount consumed, 14 g of alcohol was considered a standard drink. With the non-drinker group as reference, logistic regression was used to analyze the relationship between weekly alcohol intake and prostatic hyperplasia in the flushing and non-flushing groups, with adjustment for confounding factors such as age, body mass index, smoking, and exercise patterns. Results: Individuals aged 50-59 years who experienced drinking-related facial flushing had a significantly lower risk of prostatic hyperplasia than the non-drinker group, depending on alcohol consumption: ≤4 standard drinks (adjusted odds ratio [OR], 0.38; 95% confidence interval [CI], 0.16 to 0.86); >4 ≤8 standard drinks (OR, 0.35; 95% CI, 0.13 to 0.95); >8 standard drinks (OR, 0.33; 95% CI, 0.13 to 0.84). However, no significant relationship was observed between the number of drinks consumed and the risk of prostate hyperplasia in the non-flushing group. Conclusion: The risk of prostatic hyperplasia appears to be reduced by alcohol consumption among Korean men aged 50-59 years who exhibit drinking-related facial flushing.
introDUCtion
Prostatism refers to the enlargement of the prostate, also known as benign prostatic hyperplasia, and is pathologically diagnosed as prostatic stromal cell or epithelial cell proliferation. This condition is closely associated with aging. According to Western studies, 40%-70% of the male population aged ≥60 years are affected. 1) In Korea, 22% of men aged ≥50 years have lower urinary tract symptoms related to benign prostatic hyperplasia, which lowers their quality of life. 2) Because of the increasing interest in the quality of life among the aging population, benign prostatic hyperplasia has gained importance as a national health issue. Therefore, many studies are under way to investigate the prevalence, cause, and risk factors of benign prostatic hyperplasia in Korea at the community level.
According to a study recently conducted in local communities in Korea, the prevalence of benign prostatic hyperplasia was 36% for men in their 60s, 43% for men in their 70s, and 53% for men in their 80s. The prevalence after adjusting for age was 42%, indicating that the prevalence of benign prostatic hyperplasia had increased compared to that reported in previous studies. 3) Some epidemiologic studies have suggested that metabolic syndrome, with clinical features of insulin resistance, lipid metabolism abnormalities, hypertension, and abdominal obesity, appears more frequently in patients with benign prostatic hyperplasia than in unaffected men of the same age group. 4, 5) Platz et al. 6) reported that the risk of benign prostatic hyperplasia was lower in those who consumed an appropriate amount of alcohol (30.1-50.0 g/ d). Similarly, in Korea, Lee et al. 7) conducted a study on 514 Korean men and confirmed an inverse relationship between alcohol consumption and benign prostatic hyperplasia.
Although the precise mechanisms underlying this relationship have not yet been elucidated, it is believed that blood estrogen level increases with the quantity of alcohol consumed, while androgen and testosterone levels decrease, ultimately reducing the risk of benign prostatic hyperplasia. 8, 9) Since alcohol metabolism depends on a genetic polymorphism of the aldehyde dehydrogenase 2 (ALDH2) gene, the amount of acetaldehyde produced by the action of ALDH2 is different for each individual, even if the same amount of alcohol is consumed. Most alcohol is broken down through the oxidative pathway where ADH and ALDH2
react. ALDH2 is a protein isoform of aldehyde dehydrogenase, which exists in mitochondria. The ALDH2 polymorphism known as ALDH2*2 is common in Northeast Asians, 10) and this ALDH2 polymorphism results in low enzyme activity.
A recent study reported that ALDH2 is related to chronic age-associated diseases such as coronary artery disease and hypertension.
11)
Seok et al, 12) conducted a study on the relationship between missense ALDH2 (SNP: Glu504Lys) and benign prostatic hyperplasia in Koreans.
Facial flushing and various unpleasant physiological responses can occur after alcohol consumption. Alcohol-induced facial flushing occurs because of a lack of the ALDH2 enzyme, which is one of the isoenzymes of ALDH. 13) However, no studies have been reported so far on the association between facial flushing and prostatic hyperplasia. Accordingly, this study investigated whether the relationship between the amount of alcohol consumption and prostatic hyperplasia is different for drinkers with and without facial flushing. 
MetHoDs

study subjects
study Methods
The size of the prostate (in grams) was confirmed through prostate ultrasonography during the health examination. Previous studies used various criteria for the epidemiologic definition of benign prostatic hyperplasia and its size, such as prostatic symptoms, digital rectal examination, the volume on prostate ultrasonography, and uroflowmetry.
This study defined prostatic hyperplasia as the presence of a prostate that exceeded 20 g, based on Garraway et al. 14) Alcohol consumption habits, smoking habits, amount of exercise, and presence of facial flushing after consuming alcohol were investigated through self-administered questionnaires, after which primary physicians performed interviews. The study subjects were divided into groups based on their age: those in their 40s, 50s, and 60s. They were also categorized into drinkers and non-drinkers, and the drinkers were sub-categorized into those with and without flushing (flushing and non-flushing group).
Height (m) and weight (kg) were measured with an automatic height-weight measuring device, and height (m) was divided by the square of weight (kg) to calculate the body mass index (BMI). For smoking habits, subjects were divided into those who had never smoked, those who had smoked in the past, and those who were currently smoking. For exercise habits, subjects were classified into four groups depending on whether they performed medium-to-high intensity exercise for longer than 30 minutes: those who did not work out; those who worked out irregularly (once or twice per week); those who worked out regularly (three to five times per week); and those who worked out almost every day.
statistical Analysis
The demographic characteristics of the non-drinkers, flushing, and non-flushing groups were expressed as mean±standard deviation. T-tests were conducted to compare the age, BMI, and prostate size, while the chi-square test was used to compare smoking and amount of exercise, with non-drinkers being the control group.
The flushing and non-flushing groups were divided into three subgroups based on the amount of alcohol consumption per week: ≤4 standard drinks, >4 ≤8 standard drinks, and >8 standard drinks. In order to determine the relationship between the amount of alcohol consumption, flushing status, and prostatic hyperplasia, multivariate logistic regression was used to investigate the relative risk of prostatic hyperplasia in the subgroups in relation to the amount of alcohol consumed, after adjustment for other variables (age, BMI, amount of exercise, smoking habits) based on the non-drinker group. P<0.05 was considered to be statistically significant, and IBM SPSS ver. 21.0 (IBM Corp., Armonk, NY, USA) was used for the statistical analyses. resUlts
General Characteristics and Alcohol-related Characteristics of the study subjects
Among the 957 subjects, 180 were included in the non-drinker group, 389 in the flushing group, and 388 in the non-flushing group. The age of the subjects was 54.8±7.6 years in the non-drinkers group, 52.0±7.5 years in the flushing group, and 51.1±6.9 years in the non-flushing group, indicating that the age of the drinkers in both the flushing (P<0.001) and non-flushing groups (P<0.001) was significantly lower than that of the non-drinkers.
The proportion of smokers was significantly higher among drinkers, (Table 1) .
risk of Prostatic Hyperplasia by Age Group Based on the Amount of Alcohol Consumption in the flushing Group
Twenty-nine (64.4%) of 45 non-drinkers in their 40s had prostatic hyperplasia. In the flushing group for this same age range, 51 drinkers (64.6%) who had less than four drinks per week, 21 (77.8%) of the drinkers who had four to eight drinks per week, and 25 (65.8%) of the drinkers who had more than eight drinks per week had prostatic hyperplasia. Analysis using the chi-square test for trend in this group (flushing, 40s) showed that the incidence of prostatic hyperplasia had no statistically significant relation with the amount of alcohol consumption (P=0.659).
Among the subjects in their 50s, 72 (87. 
risk of Prostatic Hyperplasia by Age Group Based on the Amount of Alcohol Consumption in the non-flushing Group
The non-flushing group was also analyzed according to the same age groups. The distribution of prostatic hyperplasia according to the weekly alcohol consumption for each age group was compared to that of the non-drinkers, and the difference was not statistically significant (Table 2 ). Using multivariate logistic regression, with adjustment for ‡ Medium-to-high intensity exercise lasting more than 30 minutes: those who did not work out; worked out irregularly (one or two times a week); worked out regularly (three to five times a week); and worked out almost every day. § 1 standard drink=14 g of alcohol.
confounding factors such as age, BMI, amount of exercise, and smoking status, the risk of prostatic hyperplasia in the non-flushing group compared to the non-drinkers was calculated. The odds ratio (95% CI) for the group in their 40s were 1.37 (0.60-3.14) for drinkers who had less than four drinks per week, 0.42 (0.14- (Table 3) .
DisCUssion
This study investigated the relationship between prostatic hyperplasia and alcohol consumption, based on the presence or absence of facial flushing after drinking. The current study demonstrated that drinkers in their 50s with facial flushing have a lower risk of developing prostatic hyperplasia than do non-drinkers.
Male hormones need to be supplied consistently in order to develop the prostate and to maintain the function of secretion normally. Men who are castrated before adolescence or who genetically lack androgens experience a rapid cell transformation of the prostatic tissues, which eventually leads to shrinking of the prostate; therefore, they do not develop benign prostatic hyperplasia. In castrated mice, the prostate regrows when male hormones are injected. [15] [16] [17] [18] Androgens are therefore definitely important in the occurrence of prostatic hyperplasia.
The risk of benign prostatic hyperplasia in terms of alcohol consumption, age, race, BMI, and the extent of exercise has been investi- The prostate is highly dependent on male hormones, and many studies have reported that alcohol changes the concentration of blood testosterone, a male hormone. When nine men were asked to consume 1.3 g/kg of alcohol around the same time each day for seven days or the same amount of alcohol all at once within 30 minutes, all of them showed hormonal changes and their testosterone level decreased. 21) In another study, healthy men were asked to consume a set amount of alcohol for four weeks along with balanced meals to examine the effect of alcohol on their testosterone level; the result showed that temporary alcohol consumption and repetitive alcohol consumption lowered the concentration of blood testosterone. 22) Moreover, men with alcoholic liver cirrhosis tended to have hypogonadism or become feminized; in such cases, decreased testosterone levels and the resultant increase in estrogen levels lead to a lower risk of benign prostatic hyperplasia, based on autopsy results. 23, 24) However, in other experiments androgens did not play a role as a growth factor of cultured prostate epithelial cells. 25) Compared with various studies of the impact of alcohol consumption on benign prostatic hyperplasia, the current study is unique in that it divided drinkers into those with facial flushing and those without facial flushing. In this study, drinkers in their 50s with facial flushing showed a decrease in the risk of prostatic hyperplasia relative to non-drinkers. Drinkers with facial flushing after alcohol consumption have an excessive amount of acetaldehyde. In such individuals, we expect the higher concentration of aldehyde due to low ALDH2 activity to be related to a lower risk of benign prostatic hyperplasia. However, this finding conflicts with that of a study that reported aldehyde creation to be significantly increased in patients with benign prostatic hyperplasia. 26) More studies are clearly needed, since only in a specific age group, men in their 50s, did we find an inverse relationship between drinking-associated facial flushing and prostatic hyperplasia.
Additionally, further research is needed into ALDH2 activity and hormonal conditions that could explain the lower prevalence of prostatic hyperplasia in men who experience facial flushing after drinking.
This study had some limitations. First, it was difficult to find a causal relationship as the study was a cross-sectional study. Second, the sample was taken from one regional hospital in Daejeon; therefore, it is unlikely to represent the entire population of Korean men. Lastly, the study may be biased because only those who are highly interested in their health would have participated in this study.
Despite such limitations, the present study is significant in that it investigated the relationship between alcohol consumption and prostatic hyperplasia based on the presence of facial flushing after alcohol consumption. In addition, our findings suggest that the presence of alcohol-related facial flushing must be considered together with alcohol consumption by the family physician in daily clinical practice.
